[{"Assets_0_Q3_USD":2541622000.0,"CommonStockSharesOutstanding_0_Q3_shares":111325000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-82447000.0,"NetIncomeLoss_1_Q3_USD":-208535000.0,"NetIncomeLoss_3_Q3_USD":-609931000.0,"StockholdersEquity_0_Q3_USD":1607087000.0,"Ticker":"ALNY","CIK":"1178670","name":"ALNYLAM PHARMACEUTICALS, INC.","OfficialName":"Alnylam Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"19459816074.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191031"}]